3.140USD+1.62%Mkt Cap: 353.19M $P/E: —1d ago
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform…
Industry Peers
Health Information Services$33.50BUSDP/E 36.6
$11.87BUSDP/E 54.0
$8.75BUSDP/E 39.1
$8.31BUSD
$6.01BUSD
$5.97BUSD
$4.35BUSDP/E 32.4
$3.00BUSDP/E 139.9
$2.31BUSD
$1.71BUSDP/E 44.8
$1.27BUSD
$1.22BUSD
$1.21BUSD
$1.14BUSD
$1.07BUSDP/E 52.7
$872.74MUSDP/E Infinity
$827.67MUSDP/E 42.3
$698.05MUSDP/E 70.6
$567.50MUSDP/E 26.8
$519.59MUSDP/E 12.3
$537.07MUSD
$516.62MUSD
$449.55MUSDP/E 25.7
$431.44MUSDP/E 24.5
$439.47MUSDP/E 81.3
$414.09MUSD
$370.32MUSDP/E 45.8
$351.50MUSD
$232.19MUSDP/E 19.5
$193.49MUSDP/E 9.9
$169.07MUSDP/E 33.6
$180.39MUSD
$179.78MUSD
$152.20MUSDP/E 38.4
$163.31MUSD
$134.30MUSDP/E Infinity
$122.91MUSDP/E 18.2
$112.61MUSDP/E 20.4
$111.69MUSDP/E 24.9
$73.87MUSD
$69.22MUSD
$63.42MUSDP/E 11.0
$59.14MUSDP/E 21.4
$55.77MUSD
VST
Victory Square Technologies Inc.$51.61MUSDP/E 13.6
$46.69MUSDP/E 56.2
$43.00MUSDP/E 41.0
$37.55MUSD
$33.66MUSDP/E 32.5
$27.30MUSD
$23.54MUSDP/E 56.3
$24.12MUSD
$19.31MUSD
$13.30MUSD
$12.42MUSD
$11.98MUSD
$10.81MUSDP/E 16.7
$10.66MUSD
$9.20MUSD
AIML
AI/ML Innovations Inc.$8.32MUSD
$5.81MUSD
$5.19MUSD
$4.90MUSD
$3.78MUSDP/E Infinity
$2.88MUSD
$2.63MUSD
$2.68MUSD
$2.07MUSDP/E 0.0
$1.44MUSDP/E Infinity
TMED
EGF Theramed Health Corp$592.2KUSD
$480.2KUSD
$360.0KUSDP/E 0.0
$1.4KUSD
EYES
Corgi Data & Surveillance ETF—P/E 31.6
CRY
GraniteShares YieldBOOST CRCL ETF—
—
—
—
Indicators:|
Key Statistics
Company
Market Cap353.19M $
Enterprise Value1.19B $
Revenue (TTM)1.89B $
Gross Profit399.88M $
Net Income (TTM)-534.51M $
Revenue/Share16.66 USD
Last Price3.140 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.2K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)8.58
PEG1.93
EV/EBITDA16.02
EV/Revenue0.63
P/S0.18
P/B0.88
EPS (TTM)-4.68
EPS (Forward)0.36
52W Range
2.09513% of range10.25
52W High10.25 USD
52W Low2.095 USD
Profitability
Gross Margin21.31%
Oper. Margin-2.04%
EBITDA Margin3.94%
Profit Margin-28.49%
ROE-128.74%
ROA-28.14%
Growth
Revenue Growth2.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF38.84M $
CapEx (TTM)34.09M $
FCF Margin2.80%
FCF Yield14.99%
Net Debt843.40M $
Net Debt/EBITDA11.34
Balance Sheet
Debt/Equity2.38
Current Ratio1.32
Quick Ratio1.20
Book Value/Sh3.524 USD
Cash/Share1.263 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.827 USD
Upside (mean)+85.6%
Target Range3.000 USD – 8.000 USD
$3.000+85.6% to mean$8.000
# Analysts13
Ownership
Shares Out.112.48M
Float93.57M
Insiders3.18%
Institutions101.09%
Short Interest
Short Ratio6.0d
Short % Float13.21%
Short % Out.13.06%
Shares Short14.69M
Short (prev mo.)14.58M
Technical
SMA 504.759 (-34.0%)
SMA 2004.136 (-24.1%)
Beta0.77
S&P 52W Chg18.32%
Avg Vol (30d)2.73M
Avg Vol (10d)4.90M
Technical Indicators
RSI (14)25.1
MACD-0.5087
MACD Signal-0.1970
MACD Hist.-0.3117
BB Upper7.208 USD
BB Middle4.926 USD
BB Lower2.644 USD
BB Width92.66%
ATR (14)0.3973 USD
Vol Ratio (20d)0.90x